Bioresorbable materials represent an advancement in personalized implant technology. They offer temporary support structures that naturally degrade within the body as healing progresses. Our research focuses on developing bioresorbable implants tailored to individual patient needs, particularly in dentistry, pediatric surgery, and craniofacial reconstruction.

One key focus of our research is optimizing the material properties of these bioresorbable implants to ensure they maintain their structural integrity long enough to support the healing process. We are investigating a variety of bioresorbable polymers, including polylactic acid (PLA), polycaprolactone (PCL), polyglycolic acid (PGA), and their copolymers, which are known for their biocompatibility and predictable degradation rates. These materials are engineered to degrade at a controlled rate, providing sufficient support during the critical phases of tissue regeneration. Our research also aims to enhance the performance of personalized bioresorbable implants by integrating bioactive molecules that can promote faster healing and reduce inflammation. Incorporating these molecules into the implant creates a bioactive environment supporting tissue regeneration and improving patient outcomes. Our goal is to provide surgeons with innovative, safe, and practical solutions to enhance patient care and outcomes in various clinical applications.